TWI565469B - Herbal composition for cardiovascular health - Google Patents

Herbal composition for cardiovascular health Download PDF

Info

Publication number
TWI565469B
TWI565469B TW104118476A TW104118476A TWI565469B TW I565469 B TWI565469 B TW I565469B TW 104118476 A TW104118476 A TW 104118476A TW 104118476 A TW104118476 A TW 104118476A TW I565469 B TWI565469 B TW I565469B
Authority
TW
Taiwan
Prior art keywords
weight
parts
extract
extraction
chinese herbal
Prior art date
Application number
TW104118476A
Other languages
Chinese (zh)
Other versions
TW201642870A (en
Inventor
褚俊傑
涂祐銘
楊凱麟
蔡朋呈
鄭秀娟
劉詩敏
Original Assignee
南臺科技大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 南臺科技大學 filed Critical 南臺科技大學
Priority to TW104118476A priority Critical patent/TWI565469B/en
Publication of TW201642870A publication Critical patent/TW201642870A/en
Application granted granted Critical
Publication of TWI565469B publication Critical patent/TWI565469B/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

有助於心血管保健之中草藥組合物 Helps cardiovascular health care herbal composition

本發明係有關於一種能防止血管硬化、促進血液循環、降低血中三酸甘油脂的中草藥組合物。 The present invention relates to a Chinese herbal medicine composition capable of preventing hardening of blood vessels, promoting blood circulation, and lowering triglyceride in blood.

根據相關文獻統計,全球每年死亡人數中有三分之一是死於心血管疾病,以台灣而言,心血管疾病也威脅著50歲以上的中老年人。 According to relevant literature, one-third of the world's annual deaths are due to cardiovascular disease. In Taiwan, cardiovascular disease also threatens middle-aged and older people over the age of 50.

所謂心血管疾病(Cardiovascular disease,CVD)泛指所有心臟及血管的病變,種類包括有冠狀動脈心臟病、心臟麻痺、心絞痛、心肌梗塞、心律不整、出血性心臟衰竭等,皆屬於多重致病機轉及因子的疾病。 Cardiovascular disease (CVD) refers to all heart and blood vessel diseases, including coronary heart disease, cardiac paralysis, angina pectoris, myocardial infarction, arrhythmia, hemorrhagic heart failure, etc., all of which are multiple pathogenesis machines. Diseases that turn to factors.

心血管疾病的致病因子是由多重內生與外源性危險因子交互作用而逐漸誘發病變,產生的主要原因,是由於脂肪與膽固醇沉積,最重要的病理變化為動脈硬化。動脈硬化包括動脈壁的增厚與 硬化,由於動脈內徑縮減導致通過血流量減少,而動脈壁增厚及硬化失去收縮及放鬆能力及部分彈力。若發生在腦動脈則造成腦中風,若發生在冠狀動脈則造成心肌梗塞。血漿脂質異常與氧化壓力(Oxidative stress)是趨動動脈粥樣硬化最直接的危險因素,臨床檢驗與流行病學以血脂異常作為動脈粥樣硬化的評估指標:TC偏高(250mg/dl)、TG偏高(>200mg/dl)、LDL-C上升(200mg/dl)及HDL-C偏低(<35mg/dl)。在許多動物實驗均指出,膳食膽固醇的攝取會使血漿總膽固醇(total cholesterol,TC)上升,並使血漿中低密度脂蛋白(low density lipoprotein-cholesterol,LDL-TC)顆粒變大且數目增多,而提高了罹患心血管疾病之機率。 The causative agent of cardiovascular disease is caused by the interaction of multiple endogenous and exogenous risk factors, and the main cause is the deposition of fat and cholesterol. The most important pathological change is arteriosclerosis. Arteriosclerosis includes thickening and hardening of the arterial wall, which is reduced by blood flow due to the reduction of the inner diameter of the artery, and the contraction and relaxation ability and partial elasticity of the arterial wall are thickened and hardened. If it occurs in the cerebral artery, it causes a stroke in the brain, and if it occurs in the coronary artery, it causes myocardial infarction. Plasma lipid abnormalities and Oxidative stress are the most direct risk factors for atherosclerosis. Clinical tests and epidemiology use dyslipidemia as an indicator of atherosclerosis: TC is high ( 250mg/dl), TG is high (>200mg/dl), LDL-C is rising ( 200mg/dl) and HDL-C are low (<35mg/dl). In many animal experiments, it has been pointed out that dietary cholesterol intake will increase plasma total cholesterol (TC) and increase plasma low density lipoprotein-cholesterol (LDL-TC) particles and increase the number of particles. It increases the chance of suffering from cardiovascular disease.

與血脂異常和粥狀動脈硬化相關的腦中風和心臟病是國人健康的大敵。而造成心臟血管相關疾病的最大禍首便是高血壓、高血脂及高血糖等所謂的「三高」。根據97年台灣地區三高追蹤調查結果顯示,有高血壓、高血糖或高血脂的病人比一般人更容易發生中風、腎臟或心臟等疾病。而本發明主要係利用透過降低高血脂的機制,期能對於減低心血管疾病致病率和死亡率有所助益。 Stroke and heart disease associated with dyslipidemia and atherosclerosis are the enemy of Chinese health. The biggest cause of cardiovascular disease is the so-called "three highs" such as high blood pressure, high blood fat and high blood sugar. According to the results of the 1997 high-level follow-up survey in Taiwan, patients with high blood pressure, high blood sugar or high blood lipids are more likely to have stroke, kidney or heart disease than the average person. However, the present invention mainly utilizes a mechanism for reducing hyperlipemia, which can contribute to reducing the morbidity and mortality of cardiovascular diseases.

由於近年來隨著保健與養生觀念的興起,人們除了藉由日常規律的運動方式來保健身體健康外,透過食用保健補給品的方式也越來越受重視。因此,本發明提出一種複方的天然中草藥組合物, 期能有助於心血管之保健,而能有效降低心血管疾病的罹患率,進而達到節省醫療資源的效果。 In recent years, with the rise of the concept of health care and health care, in addition to the daily regular exercise to protect the health of the body, the way of eating health care supplies has become more and more important. Accordingly, the present invention provides a compound natural herbal composition, It can help cardiovascular health care, and can effectively reduce the incidence of cardiovascular disease, and thus achieve the effect of saving medical resources.

一種有助於心血管保健之中草藥組合物,包含6~10重量份的蛋油、10~14重量份的黑木耳萃取物、8~12重量份的黑豆萃取物、8~12重量份的刺五加萃取物、13~17重量份的決明子萃取物、10~14重量份的五味子萃取物、10~14重量份的枸杞萃取物、10~14重量份的紅棗萃取物、7~11重量份的白藜蘆醇。 A herbal composition for cardiovascular health care, comprising 6-10 parts by weight of egg oil, 10-14 parts by weight of black fungus extract, 8-12 parts by weight of black bean extract, 8-12 parts by weight of thorn Five plus extract, 13-17 parts by weight of cassia seed extract, 10-14 parts by weight of Schisandra extract, 10-14 parts by weight of strontium extract, 10-14 parts by weight of jujube extract, 7-11 parts by weight Resveratrol.

如上所述之有助於心血管保健之中草藥組合物,其中,係包含12重量份的黑木耳萃取物、8重量份的蛋油、10重量份的黑豆萃取物、10重量份的刺五加萃取物、15重量份的決明子萃取物、12重量份的五味子萃取物、12重量份的枸杞萃取物、12重量份的紅棗萃取物以及9重量份的白藜蘆醇。 The cardiovascular health care herbal composition as described above, which comprises 12 parts by weight of black fungus extract, 8 parts by weight of egg oil, 10 parts by weight of black bean extract, and 10 parts by weight of acanthopanax senticosus The extract, 15 parts by weight of cassia seed extract, 12 parts by weight of Schisandra extract, 12 parts by weight of strontium extract, 12 parts by weight of jujube extract, and 9 parts by weight of resveratrol.

如上所述之有助於心血管保健之中草藥組合物,其中,該白藜蘆醇係取自紅酒。 The above-described cardiovascular health care herbal composition is as described above, wherein the resveratrol is derived from red wine.

如上所述之有助於心血管保健之中草藥組合物,其中,各個所述萃取物是經一萃取流程而得,所述萃取流程包括製備程序與萃取程序;所述製備程序主要包括中草藥篩選與乾燥細化步驟;所述萃取程序包括萃取前處理、低溫加壓、添加助溶劑、取出萃取液、超音波震盪與乾燥步驟。 The above-mentioned cardiovascular health care herbal composition, wherein each of the extracts is obtained through an extraction process, the extraction process includes a preparation process and an extraction procedure; and the preparation process mainly includes Chinese herbal medicine screening and a drying refining step; the extraction procedure includes pre-extraction treatment, low temperature pressurization, addition of a co-solvent, removal of the extract, ultrasonic shock and drying steps.

如上所述之有助於心血管保健之中草藥組合物,其中,所述萃取程序是以75%酒精與所述萃取物之原料以1:1(v/w)方式萃取 24小時後,過濾取其上清液以65℃條件凍乾後,將其酒萃凍乾粉末以純水溶解後在100℃下進行熱水萃取30分鐘後過濾而得。 A cardiovascular health care herbal composition as described above, wherein the extraction procedure is performed in a 1:1 (v/w) manner with 75% alcohol and the extract material. After 24 hours, the supernatant was filtered and lyophilized at 65 ° C, and then the wine lyophilized powder was dissolved in pure water, and subjected to hot water extraction at 100 ° C for 30 minutes, followed by filtration.

如上所述之有助於心血管保健之中草藥組合物,其中,在所述製備程序中,於乾燥細化步驟之後,進一步包含有粗萃取與乾燥再稀釋步驟。 The cardiovascular health care herbal composition as described above, wherein, in the preparation procedure, after the drying and refining step, a crude extraction and drying and further dilution step is further included.

如上所述之有助於心血管保健之中草藥組合物,其中,進一步包括一基料成分,該基料成分選自澱粉類、豆類、五穀類、動物飼料或液體其中之一。 The cardiovascular health care herbal composition as described above, further comprising a base component selected from the group consisting of starch, legumes, grains, animal feed or liquid.

如上所述之有助於心血管保健之中草藥組合物,其中,所述中草藥組合物係呈液體之溶液、懸浮液或漿液形式,或呈固體之錠劑、膠囊劑、粉劑形式。 The cardiovascular health care herbal composition as described above, wherein the herbal composition is in the form of a liquid solution, suspension or slurry, or in the form of a solid tablet, capsule or powder.

第一圖:本發明之中草藥組合物於實驗動物之體重調節效果圖 First figure: The effect of the herbal composition of the present invention on the weight adjustment effect of experimental animals

第二圖:本發明之中草藥組合物於實驗動物之三酸甘油脂調節效果圖 The second figure: the effect of the herbal composition of the present invention on the regulation of triglyceride in experimental animals

第三圖:本發明之中草藥組合物於實驗動物之總膽固醇調節效果圖 The third figure: the effect of the total herbal cholesterol regulation of the herbal composition of the present invention on experimental animals

第四圖:本發明之中草藥組合物於實驗動物之低密度脂蛋白調節效果圖 Figure 4: Low-density lipoprotein regulation effect of the Chinese herbal composition of the present invention in experimental animals

第五圖:本發明之中草藥組合物於實驗動物之高密度脂蛋白調節效果圖 Figure 5: High-density lipoprotein regulation effect of the Chinese herbal composition of the present invention in experimental animals

第六圖:本發明之中草藥組合物於實驗動物之總膽固醇與高密度脂蛋白比值調節效果圖 Figure 6: Effect of the ratio of total cholesterol to high density lipoprotein in the experimental animal of the present invention

為令本發明所運用之技術內容、發明目的及其達成之功效有更完整且清楚的揭露,茲於下詳細說明之,並請一併參閱所揭之圖式及圖號:本發明有助於心血管保健之中草藥組合物,係包含6~10重量份的蛋油、10~14重量份的黑木耳萃取物、8~12重量份的黑豆萃取物、8~12重量份的刺五加萃取物、13~17重量份的決明子萃取物、10~14重量份的五味子萃取物、10~14重量份的枸杞萃取物、10~14重量份的紅棗萃取物、7~11重量份的白藜蘆醇。其中:蛋油(Egg oil),是把新鮮且質佳的雞蛋黃長時間不斷炒動所萃取而得的精華油。蛋油的主要成份是卵磷脂,除此之外還含有高密度脂蛋白(HDL,俗稱優質膽固醇),不飽和脂肪酸(以亞麻油酸最多),維他命E、A、D等,因為其主要成份為卵磷脂,這種對人體而言相當重要的營養素,所以一般也把蛋油別稱為蛋油卵磷脂。其主要功能有: For a more complete and clear disclosure of the technical content, the object of the invention, and the effects thereof, the present invention will be described in detail below, and reference should be made to the drawings and drawings. The cardiovascular health herbal composition comprises 6 to 10 parts by weight of egg oil, 10 to 14 parts by weight of black fungus extract, 8 to 12 parts by weight of black bean extract, and 8 to 12 parts by weight of acanthopanax senticosus. Extract, 13 to 17 parts by weight of cassia seed extract, 10 to 14 parts by weight of Schisandra extract, 10 to 14 parts by weight of strontium extract, 10 to 14 parts by weight of jujube extract, and 7 to 11 parts by weight of white Resveratrol. Among them: Egg oil is an essential oil extracted from the fresh and good egg yolk for a long time. The main ingredient of egg oil is lecithin, in addition to high-density lipoprotein (HDL, commonly known as high-quality cholesterol), unsaturated fatty acids (mostly with linoleic acid), vitamins E, A, D, etc., because of its main ingredients. It is lecithin, a nutrient that is very important to the human body, so egg oil is also commonly referred to as egg oil lecithin. Its main functions are:

1、卵磷脂是細胞膜的主要成份,能保持細胞的年輕。 1. Lecithin is the main component of the cell membrane and can keep the cells young.

2、能溶化血管壁的膽固醇,可保持血管的年輕、韌性。 2, can dissolve the cholesterol of the blood vessel wall, can maintain the young and toughness of blood vessels.

3、使腦及神經系統活潑化,對預防老化及老年癡呆症極具效果。 3, make the brain and nervous system active, very effective in preventing aging and Alzheimer's disease.

4、是一種天然的乳化劑、鎮定劑、利尿劑。 4, is a natural emulsifier, tranquilizer, diuretic.

黑木耳萃取物(Auricularia polytricha extract),其蛋白質含量是米、麵、蔬菜等所無以比擬的,其維生素B2的含量是米、麵和大白菜的十倍,比豬、牛、羊肉高3~5倍;每100克新鮮子實體內含有維生素C達200毫克;且鈣的含量是肉類的30~70倍,鐵質比肉類更高達100倍之多。就中醫而言,黑木耳味甘、性平、無毒、入胃、大腸經,具涼血止血、活血補血,利五臟、清肺益氣、宣腸健胃,消痔通便等功效。就西方醫藥的研究,能降低血液黏稠度,預防或溶解血栓,緩和冠狀動脈粥狀硬化等,其酸性多醣對小白鼠肉瘤(S-180)有42.6%的抑制效果。其主要功能如下: Auricularia polytricha extract, its protein content is unmatched by rice, noodles, vegetables, etc. Its vitamin B2 content is ten times that of rice, noodles and Chinese cabbage, higher than pig, cow and lamb. ~5 times; every 100 grams of fresh fruiting body contains vitamin C up to 200 mg; and the calcium content is 30 to 70 times that of meat, and iron is up to 100 times higher than meat. As far as Chinese medicine is concerned, black fungus is sweet, flat, non-toxic, into the stomach, large intestine, with cooling blood to stop bleeding, activating blood and blood, benefiting the five internal organs, clearing the lungs and qi, promoting the intestines and strengthening the stomach, eliminating phlegm and laxative effects. As far as Western medicine research is concerned, it can reduce blood viscosity, prevent or dissolve thrombus, and alleviate coronary atherosclerosis. Its acidic polysaccharide has a 42.6% inhibitory effect on mouse sarcoma (S-180). Its main functions are as follows:

1、活血、防止血管硬化,促進血液循環。 1. Promote blood circulation, prevent hardening of blood vessels, and promote blood circulation.

2、治外傷引起的疼痛,血脈不通,神經麻木、手足抽播。 2, treatment of pain caused by trauma, blood circulation, nerve numbness, hand and foot pumping.

3、促進排便,改善痔漏、便血,痔瘡及靜脈曲張。 3, promote bowel movements, improve leakage, blood in the stool, hemorrhoids and varicose veins.

4、治寒濕性腰腿疼痛。 4, treatment of cold and wet waist and leg pain.

5、子宮出血及閉經等婦科疾病。 5, uterine bleeding and amenorrhea and other gynecological diseases.

6、改善貧血,骨質疏鬆。 6, improve anemia, osteoporosis.

7、降血脂,對心腦血管疾患有很大助益。 7, lowering blood fat, is very helpful for cardiovascular and cerebrovascular diseases.

8、減重減肥。 8, lose weight and lose weight.

黑豆萃取物(Black bean extract),黑豆為豆科植物大豆Glycinemax(L.)merr的黑色種子。又名烏豆,黑豆,味甘性平。黑豆具有高蛋白、低熱量的特性。黑豆中所含的不飽和脂肪酸,可促進膽固醇的代謝、降低血脂,預防心血管疾病,且黑豆的纖維質含量高,可促進腸胃蠕動,預防便秘。 Black bean extract, black beans are black seeds of the legume Glycinemax (L.) merr. Also known as black beans, black beans, sweet and flat. Black beans have high protein and low calorie properties. The unsaturated fatty acids contained in black beans can promote the metabolism of cholesterol, lower blood lipids, prevent cardiovascular diseases, and the high fiber content of black beans can promote gastrointestinal motility and prevent constipation.

刺五加萃取物(Eleutherococcus senticosus extract),味辛、微苦、性溫、補中、益精、壯筋骨、強意志、益氣健脾,補腎安神。對於脾臟虛弱,體虛乏力,食慾不振,腰膝酸痛,失眠多夢尤為有效。 Eleutherococcus senticosus extract, tastes soft, slightly bitter, warm, Buzhong, Yijing, strong bones, strong will, Qi and spleen, kidney and soothe the nerves. For the spleen weakness, physical weakness, loss of appetite, waist and knee pain, insomnia and more dreams are particularly effective.

決明子萃取物(Cassia Seed extract),性味苦、甘、鹹,微寒,入肝、腎、大腸經。有清肝益腎,明目,利水通便作用。主治目赤腫痛,羞明淚多,青盲,雀目,頭痛頭暈,視物昏暗,肝硬化腹水,小便不利,習慣性便秘。外治腫毒、癬疾等。 Cassia Seed extract, bitter, sweet, salty, slightly cold, into the liver, kidney, large intestine. There are Qinggan Yishen, eyesight, and water and laxative effect. Indications of red eyes and swelling, shame and tears, blue-blind, finch, headache, dizziness, dim vision, cirrhosis, ascites, urinary adverse, habitual constipation. External treatment of swollen poison, dysentery and so on.

五味子萃取物(Schisandra chinensis extract),性味酸、甘、溫。歸肺、心、腎經。功效斂肺、滋腎、生津、收汗、澀精。主治治肺虛喘咳,口乾作渴,自汗,盜汗,勞傷羸瘦,夢遺滑精,久瀉久痢。 Schisandra chinensis extract, which is sour, sweet and warm. Return to the lungs, heart, kidney. Efficacy of lungs, kidney, Shengjin, sweating, phlegm. Indications treatment of lung deficiency and asthma cough, dry mouth for thirst, spontaneous sweating, night sweats, labor injury and thin, dreams slippery essence, long time diarrhea.

枸杞萃取物(Goji berry extract),性甘、平,歸肝腎經,具有滋補肝腎,養肝明目的功效,含有胡蘿蔔素、甜菜鹼、維生素A、維生素B1、維生素B2、維生素C和鈣、磷、鐵等,具有增加白細胞活性、促進肝細胞新生的藥理作用,還可降血壓、降血糖、血脂。 Goji berry extract, sweet, flat, liver and kidney, has nourishing liver and kidney, nourishing liver and eyesight, contains carotene, betaine, vitamin A, vitamin B1, vitamin B2, vitamin C and calcium, phosphorus Iron, etc., has the pharmacological effects of increasing white blood cell activity, promoting hepatocyte regeneration, and lowering blood pressure, lowering blood sugar, and blood lipids.

紅棗萃取物(Jujube extract),味甘性溫、脾胃經,有補中益氣,養血安神,緩和藥性的功能能使血中含氧量增強、滋養全身細胞。 Jujube extract, sweet and warm, spleen and stomach, with Buzhong Yiqi, nourishing blood and calming the nerves, and alleviating the medicinal function can enhance the oxygen content in the blood and nourish the whole body cells.

白藜蘆醇(Resveratrol),可以延長某些細胞的生命週期達70%,具抗氧化的效果,增進活力以及適當的改變基因表現的形式。 Resveratrol can extend the life cycle of certain cells by up to 70%, has antioxidant effects, enhances vitality and appropriately alters the form of gene expression.

其中,各萃取物是經一萃取流程而得,此萃取流程包括製備程序與萃取程序。 Wherein, each extract is obtained through an extraction process, and the extraction process includes a preparation process and an extraction process.

製備程序主要包括中草藥篩選與乾燥細化步驟;而萃取程序則包括萃取前處理、低溫加壓、添加助溶劑、取出萃取液、超音波震盪與乾燥等步驟。 The preparation procedure mainly includes a Chinese herbal medicine screening and drying refining step; and the extraction procedure includes steps of pre-extraction treatment, low-temperature pressurization, addition of a co-solvent, removal of the extract, ultrasonic vibration and drying.

進一步詳言,該萃取程序是以75%酒精與所述萃取物之原料以1:1(v/w)方式萃取24小時後(萃取前處理),過濾取其上清液以65℃條件凍乾後(低溫加壓),將其酒萃凍乾粉末以純水溶解後(添加助溶劑),在100℃下進行熱水萃取30分鐘後過濾而得(超音波震盪與乾燥)。 Further, the extraction procedure is to extract the raw material of the extract with 75% alcohol and the extract in a 1:1 (v/w) manner for 24 hours (pre-extraction treatment), and filter the supernatant to freeze at 65 ° C. After drying (low temperature pressurization), the wine lyophilized powder is dissolved in pure water (adding a co-solvent), and subjected to hot water extraction at 100 ° C for 30 minutes, followed by filtration (ultrasonic shock and drying).

此外,在上述製備程序中,於乾燥細化步驟之後,係能進一步包含粗萃取與乾燥再稀釋步驟。 Further, in the above preparation procedure, after the drying and refining step, the step of further extracting and drying and further diluting may be further included.

其中,本發明之有助於心血管保健之中草藥組合物進一步包括一基料成分,該基料成分為一選自下列群組中的物質:澱粉類、豆類、五穀類、動物飼料及液體。且該有助於心血管保健之中草藥組合物可呈液體之溶液、懸浮液及漿液形式,或可呈固體之錠劑、膠囊劑、粉劑之形式。 Wherein, the herbal health care herbal composition of the present invention further comprises a base ingredient which is a substance selected from the group consisting of starch, beans, grains, animal feed and liquid. Moreover, the herbal composition for cardiovascular health care can be in the form of a liquid solution, a suspension and a slurry, or can be in the form of a solid tablet, capsule or powder.

而該白藜蘆醇係取自紅酒。 The resveratrol is taken from red wine.

<實施例> <Example>

本發明之有助於心血管保健之中草藥組合物由12重量份的黑木耳萃取物、8重量份的蛋油、10重量份的黑豆萃取物、10重量份的刺五加萃取物、15重量份的決明子萃取物、12重量份的五味子萃取物、12重量份的枸杞萃取物、12重量份的紅棗萃取物以及9重量份的白藜蘆醇組成。 The cardiovascular health care herbal composition of the present invention comprises 12 parts by weight of black fungus extract, 8 parts by weight of egg oil, 10 parts by weight of black bean extract, 10 parts by weight of acanthopanax extract, 15 weight A portion of cassia seed extract, 12 parts by weight of Schisandra extract, 12 parts by weight of strontium extract, 12 parts by weight of jujube extract, and 9 parts by weight of resveratrol.

將本發明之中草藥組合物進行動物實驗,以驗證本發明之中草藥組合物確實有助於心血管之保健。其中,本實驗所使用之動物為購買自樂斯科生技股份有限公司(BioLASCO Taiwan Co.Ltd,Taiwan)的雄性ICR小鼠(ICR mice)。ICR小鼠皆為6週齡,體重約為32g,飼養於不鏽鋼鐵籠中,並以自動定時器控制光照週期,且給予一日12小時照明,08:00~20:00為光照期(light period), 20:00~08:00為黑暗期(dark period),環境溫度約維持於21±2℃,相對溼度50-70%。 The herbal composition of the present invention was subjected to an animal experiment to verify that the herbal composition of the present invention does contribute to cardiovascular health care. Among them, the animals used in this experiment were male ICR mice (ICR mice) purchased from BioLASCO Taiwan Co. Ltd., Taiwan. ICR mice are 6 weeks old and weigh about 32g. They are housed in stainless steel iron cages and controlled by an automatic timer. They are given 12 hours of illumination per day and 08:00~20:00 for light. Period), 20:00~08:00 is the dark period, the ambient temperature is maintained at 21±2°C, and the relative humidity is 50-70%.

本實驗主要根據「實驗動物管理與使用指南」及Guidelines of Care and Use of Laboratory Animals進行。實驗動物進入動物中心後先以正常飼料(Basal diet,Product Code 5755)及逆滲透水採自由進食供應餵食二週適應期,全部實驗動物隨機分成2組:正常組(n=8)繼續餵食鼠科正常飼料(<實驗組1>),疾病動物組(n=24)餵食2%高膽固醇飼料(成份組成如表一)。餵食12週2%高膽固醇飼料後,觀察誘導出高膽固醇血症後,隨機分為以下<實驗組2>、<實驗組3>、<實驗組4>,並投予不同藥物(或生理食鹽水)連續口服餵食4週後,觀察其是否可降低高膽固醇血症及停止餵食後8週後可否延緩粥狀動脈硬化症的發生。 This experiment was conducted mainly in accordance with the "Guidelines for the Management and Use of Laboratory Animals" and the Guidelines of Care and Use of Laboratory Animals. After entering the animal center, the experimental animals were fed with normal feed (Basal diet, Product Code 5755) and reverse osmosis water for feeding for two weeks. All the experimental animals were randomly divided into two groups: the normal group (n=8) continued to feed the rats. The normal diet (<experiment group 1>) and the diseased animal group (n=24) were fed 2% high cholesterol feed (the composition is shown in Table 1). After feeding 12% high cholesterol diet for 12 weeks, after observing hypercholesterolemia, the following were randomly divided into the following <Experimental Group 2>, <Experimental Group 3>, <Experimental Group 4>, and different drugs (or physiological saline) were administered. Water) After 4 weeks of oral feeding, it was observed whether it could reduce hypercholesterolemia and delay the onset of atherosclerosis after 8 weeks from the start of feeding.

<實驗組1> <Experimental group 1>

6週雄性ICR組+正常飼料(當衛兵對照組)-ICR小白鼠8隻給予正常飼料並任其自由取食及飲水,共餵食8週。 6-week male ICR + normal feed (when the guards were in control) - 8 ICR mice were given normal feed and allowed free access to food and water for a total of 8 weeks.

<實驗組2> <Experimental group 2>

6週雄性ICR組+2%高膽固醇飼料(當空白對照組)-ICR小白鼠6隻給予內含2%高膽固醇之飼料,餵食12週後給予正常飲水及任其自由取食及飲水,開始胃管餵食生理食鹽水共4週。 6 weeks male ICR group + 2% high cholesterol feed (when the blank control group) - ICR mice 6 were given 2% high cholesterol feed, after 12 weeks of feeding, given normal drinking water and free access to food and water, began The gastric tube was fed with physiological saline for 4 weeks.

<實驗組3> <Experimental group 3>

6週雄性ICR組+2%高膽固醇飼料(當正對照)-ICR小白鼠6隻給予內含2%高膽固醇之飼料,餵食12週後給予正常飲水及任其自由取食及飲水,開始胃管餵食Clofibrate 10mg/kg共4週。 6 weeks male ICR group + 2% high cholesterol feed (when positive control) - 6 ICR mice were given 2% high cholesterol feed, given normal drinking water after 12 weeks of feeding and allowed to freely feed and drink, start stomach The tube was fed with Clofibrate 10 mg/kg for 4 weeks.

<實驗組4> <Experimental group 4>

6週雄性ICR組+2%高膽固醇飼料(當實驗組)-ICR小白鼠6隻給予內含2%高膽固醇之飼料,餵食12週後給予正常飲水及任其 自由取食及飲水,開始胃管餵食本發明中草藥組合物100mg/kg(n=6),共4週、連續28天。 6-week male ICR group + 2% high-cholesterol diet (when experimental group) - 6 ICR mice were given 2% high cholesterol feed, given normal drinking water after 12 weeks of feeding and allowed to Free feeding and drinking, starting the gastric tube feeding of the Chinese herbal medicine composition of the present invention 100 mg / kg (n = 6) for 4 weeks, for 28 consecutive days.

<實驗組5> <Experimental group 5>

6週雄性ICR組+2%高膽固醇飼料(當實驗組)-ICR小白鼠6隻給予內含2%高膽固醇之飼料,餵食12週後給予正常飲水及任其自由取食及飲水,開始胃管餵食本發明中草藥組合物300mg/kg(n=6),共4週、連續28天。 6-week male ICR group + 2% high-cholesterol diet (when the experimental group) - ICR mice 6 were given a diet containing 2% high cholesterol, given normal drinking water after 12 weeks of feeding and allowed to freely feed and drink, start the stomach The tube was fed with the herbal composition of the present invention at 300 mg/kg (n=6) for 4 weeks for 28 consecutive days.

第一圖~第六圖所揭示者係經上述動物試驗後ICR小白鼠體重及體內三酸甘油脂、總膽固醇、低密度脂蛋白、高密度脂蛋白、總膽固醇與高密度脂蛋白比值之結果。其中: The results shown in the first to sixth figures are the results of body weight and triglyceride, total cholesterol, low density lipoprotein, high density lipoprotein, total cholesterol and high density lipoprotein ratio in ICR mice after the above animal test. . among them:

<體重測量> <Body measurement>

第一圖係揭示經上述動物試驗後,針對實驗組1~5中的ICR小白鼠於投藥前、投藥後的體重進行觀察,其顯示連續4周口服餵食本發明中草藥組合物100mg/kg與300mg/kg後,ICR小白鼠的體重較投藥前略低。 The first figure shows that after the above animal test, the body weight of ICR mice in the experimental groups 1 to 5 was observed before and after administration, and it was shown that the Chinese herbal medicine composition of the present invention was 100 mg/kg and 300 mg orally administered continuously for 4 weeks. After /kg, the body weight of ICR mice was slightly lower than before administration.

<血液生化值測定> <Measurement of blood biochemical value>

將上述五組ICR小白鼠採血進行相關生化值檢測。ICR小白鼠如不麻醉則需以保定器保定。將尾巴置於40℃溫水中或以加熱燈照射5至10分鐘,使尾巴血管擴張,以23或21G的針頭由尾巴左右兩側之尾靜脈或腹側的尾動脈抽血,或僅以21G的蝴蝶針頭插入尾動脈中,確認有血液流出後再以採血管承接。採取約0.5ml 全血,經5000rpm 10分鐘離心後,取0.2ml血清以進行生化值實驗。 The above five groups of ICR mice were tested for biochemical values. If the ICR mouse is not anesthetized, it needs to be secured with a Baoding device. Place the tail in warm water at 40 ° C or irradiate with a heat lamp for 5 to 10 minutes to dilate the blood vessels of the tail, draw blood from the tail vein of the left and right sides of the tail or the ventral tail artery with a 23 or 21 G needle, or only 21G. The butterfly needle is inserted into the tail artery, and it is confirmed that blood is discharged and then taken up by the blood collection tube. Take about 0.5ml Whole blood, after centrifugation at 5000 rpm for 10 minutes, 0.2 ml of serum was taken for biochemical value experiments.

生化值實驗是由南台科技大學提供的全自動分析儀(HITACHI 7170 Autoanalyzer)進行分析血液總膽固醇、低密度脂蛋白膽固醇、高密度脂蛋白膽固醇及三酸甘油酯。本發明所有數據使用SigmaPlot 10.0來進行數據處理分析及繪圖。實驗結果數據統計之表示方式為平均值±標準誤差(mean±S.E.)。而樣本差異性使用ANOVA加上事後檢定(Scheffe法),計算出P值,*為P值小於0.05,**為P值小於0.005,***為P值小於0.001,其統計意義為以高膽固醇組與其他實驗組作為對比,當P值小於0.05時起即表示兩樣本在統計學上具有明顯差異。 The biochemical value experiment was performed by a fully automatic analyzer (HITACHI 7170 Autoanalyzer) provided by Nantai University of Science and Technology for analysis of blood total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglyceride. All data of the present invention were analyzed and plotted using SigmaPlot 10.0 for data processing. The statistical results of the experimental results are expressed as mean ± standard error (mean ± S. E.). The sample difference uses ANOVA plus post hoc test (Scheffe method) to calculate the P value, * is P value less than 0.05, ** is P value less than 0.005, *** is P value less than 0.001, and its statistical significance is high The cholesterol group was compared with other experimental groups. When the P value was less than 0.05, the two samples showed statistically significant differences.

<<三酸甘油脂>> <<Triglyceride>>

第二圖係揭示經上述動物試驗後,針對實驗組1~5中的ICR小白鼠於投藥前、投藥後體內的三酸甘油脂進行觀察,其顯示連續4周口服餵食本發明中草藥組合物100mg/kg與300mg/kg後,ICR小白鼠體內的三酸甘油脂均較投藥前有明顯的降低。 The second figure shows that after the above animal test, the ICR mice in the experimental groups 1 to 5 were observed before and after the administration of the triglyceride, which showed that the Chinese herbal medicine composition of the present invention was orally administered for 4 weeks. After /kg and 300mg/kg, the triglyceride in ICR mice was significantly lower than before administration.

<<總膽固醇>> <<Total cholesterol>>

第三圖係揭示經上述動物試驗後,針對實驗組1~5中的ICR小白鼠於投藥前、投藥後體內的總膽固醇進行觀察,其顯示連續4周口服餵食本發明中草藥組合物100mg/kg與300mg/kg後,ICR小白鼠體內的總膽固醇較投藥前有明顯的降低,尤其是連續4周口 服餵食本發明中草藥組合物100mg/kg之實驗組。 The third panel reveals that the total cholesterol in the ICR mice in the experimental groups 1 to 5 before and after administration was observed after the above animal test, and it was shown that the Chinese herbal medicine composition of the present invention was orally administered for 100 weeks. After 300mg/kg, the total cholesterol in ICR mice was significantly lower than before administration, especially for 4 weeks. The experimental group of the Chinese herbal medicine composition of the present invention was administered at 100 mg/kg.

<<低密度脂蛋白>> <<Low density lipoprotein>>

第四圖係揭示經上述動物試驗後,針對實驗組1~5中的ICR小白鼠於投藥前、投藥後體內的低密度脂蛋白進行觀察,其顯示連續4周口服餵食本發明中草藥組合物100mg/kg與300mg/kg後,ICR小白鼠體內的低密度脂蛋白較投藥前有明顯的降低,尤其是連續4周口服餵食本發明中草藥組合物100mg/kg之實驗組。 The fourth panel reveals that after the above animal test, the low-density lipoprotein of the ICR mice in the experimental groups 1 to 5 was administered before and after administration, and it was shown that the Chinese herbal medicine composition of the present invention was orally administered for 4 weeks. After /kg and 300 mg/kg, the low-density lipoprotein in the ICR mice was significantly lower than before administration, especially the experimental group in which the Chinese herbal medicine composition of the present invention was 100 mg/kg orally administered for 4 weeks.

<<高密度脂蛋白>> <<High Density Lipoprotein>>

第五圖係揭示經上述動物試驗後,針對實驗組1~5中的ICR小白鼠於投藥前、投藥後體內的高密度脂蛋白進行觀察,其顯示連續4周口服餵食本發明中草藥組合物100mg/kg與300mg/kg後,ICR小白鼠體內的高密度脂蛋白較投藥前互有高低。 The fifth figure reveals that after the above animal test, the high-density lipoprotein of the ICR mice in the experimental groups 1 to 5 was administered before and after administration, and it was shown that the Chinese herbal medicine composition of the present invention was orally administered for 4 weeks. After /kg and 300mg/kg, the high-density lipoprotein in ICR mice was higher than before.

<<總膽固醇與高密度脂蛋白比值>> <<Total cholesterol and high density lipoprotein ratio>>

第六圖係揭示經上述動物試驗後,針對實驗組1~5中的ICR小白鼠於投藥前、投藥後體內的總膽固醇與高密度脂蛋白比值進行觀察,其顯示連續4周口服餵食本發明中草藥組合物100mg/kg與300mg/kg後,ICR小白鼠體內的總膽固醇與高密度脂蛋白比值較投藥前有明顯的降低,尤其是連續4周口服餵食本發明中草藥組合物100mg/kg之實驗組。 The sixth figure shows that after the above animal test, the ratio of total cholesterol to high-density lipoprotein in the ICR mice in the experimental groups 1 to 5 before and after administration was observed, and it was shown that the invention was orally administered for 4 weeks. After the Chinese herbal medicine composition 100mg/kg and 300mg/kg, the ratio of total cholesterol to high-density lipoprotein in ICR mice was significantly lower than that before administration, especially the experiment of orally feeding the Chinese herbal medicine composition 100mg/kg for 4 weeks. group.

由第一圖~第六圖的動物試驗數據可知,本案之組合物對於 調節三酸甘油脂、總膽固醇、低密度脂蛋白、總膽固醇與高密度脂蛋白比值皆有相當不錯的效果,在調節體重與高密度脂蛋白也略有成效,尤其投藥量為100mg/kg有較佳的降低三酸甘油脂、總膽固醇、低密度脂蛋白、總膽固醇與高密度脂蛋白比值之效果。 From the animal test data of the first to sixth figures, the composition of the present case is Adjusting the ratio of triglyceride, total cholesterol, low-density lipoprotein, total cholesterol and high-density lipoprotein has a very good effect, and it is also effective in regulating body weight and high-density lipoprotein, especially when the dosage is 100mg/kg. It is preferred to reduce the effects of triglyceride, total cholesterol, low density lipoprotein, total cholesterol and high density lipoprotein ratio.

以上所舉者僅係本發明之部份實施例,並非用以限制本發明,致依本發明之創意精神及特徵,稍加變化修飾而成者,亦應包括在本專利範圍之內。 The above is only a part of the embodiments of the present invention, and is not intended to limit the present invention. It is intended to be included in the scope of the present invention.

綜上所述,本發明實施例確能達到所預期之使用功效,又其所揭露之具體技術手段,不僅未曾見諸於同類產品中,亦未曾公開於申請前,誠已完全符合專利法之規定與要求,爰依法提出發明專利之申請,懇請惠予審查,並賜准專利,則實感德便。 In summary, the embodiments of the present invention can achieve the expected use efficiency, and the specific technical means disclosed therein have not been seen in similar products, nor have they been disclosed before the application, and have completely complied with the patent law. The regulations and requirements, the application for invention patents in accordance with the law, and the application for review, and the grant of patents, are truly sensible.

Claims (6)

一種中草藥組合物,包含6~10重量份的蛋油、10~14重量份的黑木耳萃取物、8~12重量份的黑豆萃取物、8~12重量份的刺五加萃取物、13~17重量份的決明子萃取物、10~14重量份的五味子萃取物、10~14重量份的枸杞萃取物、10~14重量份的紅棗萃取物、7~11重量份的白藜蘆醇;其中,該些所述萃取物是經一萃取流程而得,所述萃取流程包括製備程序與萃取程序;所述製備程序主要包括中草藥篩選與乾燥細化步驟;所述萃取程序包括萃取前處理、低溫加壓、添加75%酒精、取出萃取液、超音波震盪與乾燥步驟,所述萃取程序是以75%酒精與所述萃取物之原料以1:1(v/w)方式萃取24小時後,過濾取其上清液以65℃條件凍乾後,將其酒萃凍乾粉末以純水溶解後在100℃下進行熱水萃取30分鐘後過濾而得。 A Chinese herbal medicine composition comprising 6-10 parts by weight of egg oil, 10-14 parts by weight of black fungus extract, 8-12 parts by weight of black bean extract, 8-12 parts by weight of Acanthopanax senticosus extract, 13~ 17 parts by weight of cassia seed extract, 10 to 14 parts by weight of Schisandra extract, 10 to 14 parts by weight of strontium extract, 10 to 14 parts by weight of jujube extract, and 7 to 11 parts by weight of resveratrol; The extracts are obtained through an extraction process, the extraction process includes a preparation process and an extraction process; the preparation process mainly includes a Chinese herbal medicine screening and drying refining step; the extraction process includes pre-extraction treatment, low temperature Pressurizing, adding 75% alcohol, taking out the extract, ultrasonic oscillating and drying step, the extraction procedure is followed by extraction in a 1:1 (v/w) manner with 75% alcohol and the raw material of the extract for 24 hours. After the supernatant was filtered and lyophilized at 65 ° C, the lyophilized powder of the wine extract was dissolved in pure water, and then subjected to hot water extraction at 100 ° C for 30 minutes, followed by filtration. 如申請專利範圍第1項所述之中草藥組合物,其中,係包含12重量份的黑木耳萃取物、8重量份的蛋油、10重量份的黑豆萃取物、10重量份的刺五加萃取物、15重量份的決明子萃取物、12重量份的五味子萃取物、12重量份的枸杞萃取物、12重量份的紅棗萃取物以及9重量份的白藜蘆醇。 The herbal composition according to claim 1, which comprises 12 parts by weight of black fungus extract, 8 parts by weight of egg oil, 10 parts by weight of black bean extract, and 10 parts by weight of Acanthopanax senticosus extract. 15 parts by weight of cassia seed extract, 12 parts by weight of Schisandra extract, 12 parts by weight of strontium extract, 12 parts by weight of jujube extract and 9 parts by weight of resveratrol. 如申請專利範圍第1項所述之中草藥組合物,其中,該白藜蘆醇係取自紅酒。 The Chinese herbal medicine composition according to claim 1, wherein the resveratrol is taken from red wine. 如申請專利範圍第1、2或3項所述之中草藥組合物,其中,所述中草藥組合物進一步包括一基料成分,該基料成分為一選自下列群組中的物質:澱粉類、豆類、五穀類、動物飼料及液體。 The herbal composition of claim 1, wherein the herbal composition further comprises a base component, the base component being a material selected from the group consisting of starches, Beans, grains, animal feed and liquids. 如申請專利範圍第4項所述之中草藥組合物,其中,所述中草藥組合物之基料成分為液體時,所述液體為溶液、懸浮液及漿液形式其中之一,或所述中草藥組合物之基料成分為固體時,所述固體為錠劑、膠囊劑、粉劑之形式其中之一。 The Chinese herbal medicine composition according to claim 4, wherein when the base component of the Chinese herbal medicine composition is a liquid, the liquid is one of a solution, a suspension and a slurry form, or the Chinese herbal medicine composition When the base component is a solid, the solid is one of a form of a tablet, a capsule, or a powder. 一種以申請專利範圍第1項至第5項任一項之中草藥組合物用於製備心血管保健組合物之用途,其係以一有效劑量施予一所需個體,以達到心血管保護之功效。 A use of a herbal composition according to any one of claims 1 to 5 for the preparation of a cardiovascular health care composition, which is administered to a desired individual at an effective dose to achieve cardiovascular protection .
TW104118476A 2015-06-08 2015-06-08 Herbal composition for cardiovascular health TWI565469B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW104118476A TWI565469B (en) 2015-06-08 2015-06-08 Herbal composition for cardiovascular health

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW104118476A TWI565469B (en) 2015-06-08 2015-06-08 Herbal composition for cardiovascular health

Publications (2)

Publication Number Publication Date
TW201642870A TW201642870A (en) 2016-12-16
TWI565469B true TWI565469B (en) 2017-01-11

Family

ID=58055744

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104118476A TWI565469B (en) 2015-06-08 2015-06-08 Herbal composition for cardiovascular health

Country Status (1)

Country Link
TW (1) TWI565469B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101273792A (en) * 2008-04-18 2008-10-01 陈春祥 Sanzi oral liquid and its preparing process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101273792A (en) * 2008-04-18 2008-10-01 陈春祥 Sanzi oral liquid and its preparing process

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FOOD & MACHINERY, 第24卷第1期2008年1月 J Chin Med, vol 14, no 3, p 193-203, 2003 Journal of Food Safety and Quality, vol 5, no 3, Mar 2014 中國醫訊, vol 89, p 59-63, Dec 2010 *

Also Published As

Publication number Publication date
TW201642870A (en) 2016-12-16

Similar Documents

Publication Publication Date Title
CN103355556A (en) Corn type mixed feed for weaned pig and preparation method thereof
CN101579120A (en) Nutritional food with weight-losing function and preparation method thereof
CN106215032A (en) A kind of bowel relieving weight reducing compound preparation and preparation method thereof
CN103478508A (en) Chinese medicinal composition and feed for improving chicken immunity and preparation method of composition and feed
CN106962904A (en) Ward off Gu Dan and preparation method thereof
WO2016202183A1 (en) Formula dog food and preparation method therefor
CN102511876B (en) Hawthorn red jujube thick syrup and production process thereof
CN109430854B (en) Health product and preparation method thereof
CN111467468A (en) Concentrated nutrient solution containing ginseng, cordyceps militaris, ginger and wolfberry fruit and preparation method thereof
CN106722258A (en) A kind of astaxanthin colla corii asini cake and preparation method thereof
RU2333677C2 (en) Dietary supplement
CN106070783A (en) A kind of production technology of Semen Coicis damp eliminating tea
CN1871940A (en) Guihu glue
CN102652561A (en) Vegetable protein food for treating micro-disease or assisting medicament in rehabilitating sick body and production method thereof
CN104738700B (en) A kind of loach protect liver product and preparation method thereof
CN108420890A (en) A kind of composition and preparation method thereof with effect for reducing blood fat
CN107594526A (en) A kind of algin is the preparation method of the aid digestion soft capsule preparation of capsule material
TWI565469B (en) Herbal composition for cardiovascular health
KR102173009B1 (en) Snack for cat containing korean herb medicine and its manufacturing methods
CN107233491A (en) It is a kind of to improve the antifatigue maca composition of energy
CN103933146A (en) Pollen product capable of adjusting human body immunity
CN113662068A (en) Formula and preparation method of osmanthus fragrans, medlar, ginger and sweet tea
CN103181557A (en) Nutritious food with slimming function and preparation method thereof
CN108813500B (en) Health-preserving honey paste with effects of tonifying middle-jiao and Qi, nourishing blood and soothing nerves and regulating human body functions
CN112641100A (en) Anti-depression electuary containing folic acid

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees